FTSE 100-listed Shire is said to have rebuffed a merger proposal from Japanese drugmaker Takeda.
This is paywall protected Betaville Intelligence content. You need to purchase a subscription to access this content. Or get in touch with subscription sales at ben@betaville.co.uk to find out about the different subscription packages on offer.
